Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

Grade Last Price % Change Price Change
D 6.59 1.86% 0.12
ACRV closed up 2.13 percent on Wednesday, March 27, 2024, on 36 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 1.86%
Slingshot Bullish Bullish Swing Setup 1.86%
NR7 Range Contraction 1.86%
Earnings Movers Other 1.86%
Wide Bands Range Expansion 1.86%
Gapped Up Strength 1.86%
Up 3 Days in a Row Strength 1.86%
Shooting Star Candlestick Bearish 4.03%
Upper Bollinger Band Walk Strength 4.03%
Earnings Movers Other 4.03%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 2 hours ago
Reversed from Down about 2 hours ago
10 DMA Support about 2 hours ago
Bullish 180 Entry about 2 hours ago
Slingshot Bullish Entry about 2 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

Is ACRV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.39
52 Week Low 3.19
Average Volume 76,552
200-Day Moving Average 7.58
50-Day Moving Average 4.59
20-Day Moving Average 5.54
10-Day Moving Average 6.02
Average True Range 0.69
RSI (14) 65.16
ADX 33.16
+DI 30.72
-DI 13.96
Chandelier Exit (Long, 3 ATRs) 4.84
Chandelier Exit (Short, 3 ATRs) 6.33
Upper Bollinger Bands 6.74
Lower Bollinger Band 4.34
Percent B (%b) 0.88
BandWidth 43.31
MACD Line 0.52
MACD Signal Line 0.45
MACD Histogram 0.0774
Fundamentals Value
Market Cap 143.49 Million
Num Shares 22.2 Million
EPS -2.26
Price-to-Earnings (P/E) Ratio -2.86
Price-to-Sales 0.00
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.31
Resistance 3 (R3) 7.24 6.90 7.17
Resistance 2 (R2) 6.90 6.69 6.93 7.12
Resistance 1 (R1) 6.68 6.56 6.51 6.75 7.07
Pivot Point 6.34 6.34 6.26 6.37 6.34
Support 1 (S1) 6.12 6.13 5.95 6.19 5.86
Support 2 (S2) 5.78 6.00 5.81 5.81
Support 3 (S3) 5.56 5.78 5.77
Support 4 (S4) 5.63